Arkansas Senate approves bill that would require prison inmates to receive HIV test before release

The Arkansas Senate on Monday voted 35-0 to approve a bill (HB 1444) that would require state inmates to receive HIV tests before being released, the AP/Pine Bluff Commercial reports (DeMillo, AP/Pine Bluff Commercial, 3/6).

Arkansas Rep. Fred Allen (D) in February introduced a version of the bill that would have required inmates to undergo tests for HIV and other sexually transmitted infections before being paroled.

The House public health committee previously tabled the bill but endorsed it after Allen amended the proposed legislation to require only HIV tests for all inmates being released, not just those being paroled.

Allen also removed a requirement from the original bill that all Arkansas Department of Correction employees receive an HIV test

In addition, the amended version requires inmates who test positive to be provided with counseling on treatment options.

Allen said the tests would cost the state about $34,000 annually, adding that the test would not be a condition for parole (Kaiser Daily HIV/AIDS Report, 3/1).

The bill returns to the House for members to consider amendments and then will go to Gov. Mike Beebe (D) (AP/Pine Bluff Commercial, 3/6).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug